Jiang Bian, PhD, was featured by The ASCO Post for a JAMA Oncology study examining the relationship between GLP-1 receptor agonist use and cancer risk in adults with overweight or obesity. The study found an overall reduced risk of cancer, including lower risks of endometrial, ovarian, and meningioma cancers, while also noting a potential increased risk of kidney cancer, underscoring the need for long-term follow-up.
The Latest
